vs
Clearway Energy, Inc.（CWEN）与Kiniksa Pharmaceuticals International, plc（KNSA）财务数据对比。点击上方公司名可切换其他公司
Clearway Energy, Inc.的季度营收约是Kiniksa Pharmaceuticals International, plc的1.5倍（$310.0M vs $202.1M），Kiniksa Pharmaceuticals International, plc净利率更高（7.0% vs -33.5%，领先40.6%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs 21.1%），Clearway Energy, Inc.自由现金流更多（$71.0M vs $53.3M），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs 8.6%）
NRG能源是总部位于美国得克萨斯州休斯敦的能源企业，前身为后续更名为埃克西尔能源的北方州电力公司的批发业务板块，2000年独立运营。业务覆盖发电与电力零售，拥有天然气、煤炭、石油、核能、风电、公用事业级及分布式太阳能等发电资产，服务超700万零售用户。
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
CWEN vs KNSA — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $310.0M | $202.1M |
| 净利润 | $-104.0M | $14.2M |
| 毛利率 | 51.9% | 89.6% |
| 营业利润率 | -11.9% | 9.8% |
| 净利率 | -33.5% | 7.0% |
| 营收同比 | 21.1% | 65.0% |
| 净利润同比 | -3566.7% | 259.8% |
| 每股收益（稀释后） | — | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $310.0M | $202.1M | ||
| Q3 25 | $429.0M | $180.9M | ||
| Q2 25 | $392.0M | $156.8M | ||
| Q1 25 | $298.0M | $137.8M | ||
| Q4 24 | $256.0M | $122.5M | ||
| Q3 24 | $486.0M | $112.2M | ||
| Q2 24 | $366.0M | $108.6M | ||
| Q1 24 | $263.0M | $79.9M |
| Q4 25 | $-104.0M | $14.2M | ||
| Q3 25 | $236.0M | $18.4M | ||
| Q2 25 | $33.0M | $17.8M | ||
| Q1 25 | $4.0M | $8.5M | ||
| Q4 24 | $3.0M | $-8.9M | ||
| Q3 24 | $36.0M | $-12.7M | ||
| Q2 24 | $51.0M | $-3.9M | ||
| Q1 24 | $-2.0M | $-17.7M |
| Q4 25 | 51.9% | 89.6% | ||
| Q3 25 | 70.2% | 88.8% | ||
| Q2 25 | 66.6% | 88.1% | ||
| Q1 25 | 59.1% | 87.0% | ||
| Q4 24 | 52.0% | 85.4% | ||
| Q3 24 | 72.2% | 82.1% | ||
| Q2 24 | 68.0% | 88.7% | ||
| Q1 24 | 52.1% | 86.7% |
| Q4 25 | -11.9% | 9.8% | ||
| Q3 25 | 26.1% | 13.3% | ||
| Q2 25 | 21.7% | 12.9% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | -14.5% | -15.7% | ||
| Q3 24 | 36.6% | -8.6% | ||
| Q2 24 | 23.0% | -0.1% | ||
| Q1 24 | -11.0% | -20.7% |
| Q4 25 | -33.5% | 7.0% | ||
| Q3 25 | 55.0% | 10.2% | ||
| Q2 25 | 8.4% | 11.4% | ||
| Q1 25 | 1.3% | 6.2% | ||
| Q4 24 | 1.2% | -7.3% | ||
| Q3 24 | 7.4% | -11.3% | ||
| Q2 24 | 13.9% | -3.6% | ||
| Q1 24 | -0.8% | -22.2% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.23 | ||
| Q1 25 | — | $0.11 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $231.0M | $414.1M |
| 总债务越低越好 | $7.9B | — |
| 股东权益账面价值 | $5.8B | $567.6M |
| 总资产 | $16.7B | $763.6M |
| 负债/权益比越低杠杆越低 | 1.36× | — |
8季度趋势，按日历期对齐
| Q4 25 | $231.0M | $414.1M | ||
| Q3 25 | $251.0M | $352.1M | ||
| Q2 25 | $260.0M | $307.8M | ||
| Q1 25 | $297.0M | $268.3M | ||
| Q4 24 | $332.0M | $243.6M | ||
| Q3 24 | $292.0M | $223.8M | ||
| Q2 24 | $226.0M | $218.8M | ||
| Q1 24 | $478.0M | $213.6M |
| Q4 25 | $7.9B | — | ||
| Q3 25 | $8.1B | — | ||
| Q2 25 | $8.3B | — | ||
| Q1 25 | $7.2B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $6.7B | — | ||
| Q2 24 | $6.8B | — | ||
| Q1 24 | $7.6B | — |
| Q4 25 | $5.8B | $567.6M | ||
| Q3 25 | $5.7B | $535.4M | ||
| Q2 25 | $5.5B | $495.0M | ||
| Q1 25 | $5.4B | $457.5M | ||
| Q4 24 | $5.6B | $438.4M | ||
| Q3 24 | $5.6B | $437.0M | ||
| Q2 24 | $5.7B | $435.1M | ||
| Q1 24 | $5.0B | $431.9M |
| Q4 25 | $16.7B | $763.6M | ||
| Q3 25 | $16.1B | $712.3M | ||
| Q2 25 | $16.0B | $661.1M | ||
| Q1 25 | $14.6B | $599.3M | ||
| Q4 24 | $14.3B | $580.6M | ||
| Q3 24 | $14.2B | $555.3M | ||
| Q2 24 | $14.5B | $542.4M | ||
| Q1 24 | $14.9B | $519.7M |
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 1.49× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | 1.21× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 1.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $177.0M | $53.9M |
| 自由现金流经营现金流 - 资本支出 | $71.0M | $53.3M |
| 自由现金流率自由现金流/营收 | 22.9% | 26.4% |
| 资本支出强度资本支出/营收 | 34.2% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 3.80× |
| 过去12个月自由现金流最近4个季度 | $369.0M | $136.4M |
8季度趋势，按日历期对齐
| Q4 25 | $177.0M | $53.9M | ||
| Q3 25 | $225.0M | $33.7M | ||
| Q2 25 | $191.0M | $28.1M | ||
| Q1 25 | $95.0M | $22.3M | ||
| Q4 24 | $192.0M | $18.8M | ||
| Q3 24 | $301.0M | $-2.2M | ||
| Q2 24 | $196.0M | $5.2M | ||
| Q1 24 | $81.0M | $4.0M |
| Q4 25 | $71.0M | $53.3M | ||
| Q3 25 | $144.0M | $33.0M | ||
| Q2 25 | $115.0M | $27.9M | ||
| Q1 25 | $39.0M | $22.2M | ||
| Q4 24 | $142.0M | $18.6M | ||
| Q3 24 | $266.0M | — | ||
| Q2 24 | $92.0M | — | ||
| Q1 24 | $-17.0M | $3.9M |
| Q4 25 | 22.9% | 26.4% | ||
| Q3 25 | 33.6% | 18.2% | ||
| Q2 25 | 29.3% | 17.8% | ||
| Q1 25 | 13.1% | 16.1% | ||
| Q4 24 | 55.5% | 15.2% | ||
| Q3 24 | 54.7% | — | ||
| Q2 24 | 25.1% | — | ||
| Q1 24 | -6.5% | 4.9% |
| Q4 25 | 34.2% | 0.3% | ||
| Q3 25 | 18.9% | 0.4% | ||
| Q2 25 | 19.4% | 0.1% | ||
| Q1 25 | 18.8% | 0.1% | ||
| Q4 24 | 19.5% | 0.2% | ||
| Q3 24 | 7.2% | 0.0% | ||
| Q2 24 | 28.4% | 0.0% | ||
| Q1 24 | 37.3% | 0.1% |
| Q4 25 | — | 3.80× | ||
| Q3 25 | 0.95× | 1.83× | ||
| Q2 25 | 5.79× | 1.58× | ||
| Q1 25 | 23.75× | 2.61× | ||
| Q4 24 | 64.00× | — | ||
| Q3 24 | 8.36× | — | ||
| Q2 24 | 3.84× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
